Company profile
Vycor Medical, Inc.
OTC: VYCO · Healthcare · Medical - Devices
#808 of 1,418 Healthcare companies by revenue63rd-percentile growth
EA Score
56CFH 56DQ 54GM 69SS 39
v0.1 · 65/100 weight · provisional
↑ disclosure history, Piotroski F · ↓ balance-sheet leverage, Altman-Z
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
+11.7%
Net income (FY)
-$72.4k
Employees
7
as of 2026-08-25
Market cap
$2.3M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.9M$1.9M2025
Net income-$72.4k-$72.4k2025
Operating income$33.9k$33.9k2025
Total assets$830.4k$830.4k2025
Liabilities$4.9M$4.9M2025
Equity-$4.1M-$4.1M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Vycor Medical, Inc.’s revenue?
Vycor Medical, Inc. booked $1.9M in FY2025 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -3.9% net margin.
Peers · Healthcare
Veltex Corporation50DBio Essence Corporation52DResonate Blends, Inc.——PharmaCielo Ltd.41DWest Island Brands Inc.——BioRegenx, Inc.30DNeighbors
Palm Beach →Key facts
CEOPeter C. Zachariou
SectorHealthcare
IndustryMedical - Devices
HeadquartersBoca Raton, FL
ExchangeOTC: VYCO
Employees7
IPO date2013-01-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.